The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Cardiome Pharma Corp closed at $11.98.

Over the last five days, shares have gained 0.76% and 12.17% year to date. Shares have outperformed the S&P TSX by 42.09% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.81
Updated November 26 3:02 PM EST. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.16%Sector:HealthcareIndustry:Biotechnology

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Total other revenue--------
Total revenue5657
Gross profit4543
Total cost of revenue1114
Total operating expense1013813
Selling / general / administrative8869
Research & development0300
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-5-7-3-6
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Income before tax-6-7-4-7
Income after tax-6-7-4-6
Income tax, total0000
Net income-6-7-4-6
Total adjustments to net income--------
Net income before extra. items-6-7-4-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-7-4-6
Inc. avail. to common incl. extra. items-6-7-4-6
Diluted net income-6-7-4-6
Dilution adjustment--------
Diluted weighted average shares19171717
Diluted EPS excluding extraordinary itemsvalue per share-0.31-0.43-0.23-0.39
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.31-0.43-0.23-0.39